Vanguard Group’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
|
|||||
|
2025
Q1 | $1.27M | Buy |
|
|||||
|
2024
Q4 | $977K | Sell |
|
|||||
|
2024
Q3 | $1.53M | Sell |
|
|||||
|
2024
Q2 | $1.4M | Buy |
|
|||||
|
2024
Q1 | $267K | Hold |
|
|||||
|
2023
Q4 | $123K | Buy |
|
|||||
|
2023
Q3 | $60.7K | Sell |
|
|||||
|
2023
Q2 | $72.4K | Sell |
|
|||||
|
2023
Q1 | $73.3K | Sell |
|
|||||
|
2022
Q4 | $309K | Buy |
|
|||||
|
2022
Q3 | $539K | Sell |
|
|||||
|
2022
Q2 | $804K | Hold |
|
|||||
|
2022
Q1 | $1.58M | Sell |
|
|||||
|
2021
Q4 | $1.93M | Sell |
|
|||||
|
2021
Q3 | $3.51M | Buy |
|
|||||
|
2021
Q2 | $4.3M | Sell |
|
|||||
|
2021
Q1 | $5.23M | Buy |
|
|||||
|
2020
Q4 | $462K | Buy |
|
|||||
|
2020
Q3 | $318K | Buy |
|
|||||
|
2020
Q2 | $265K | Hold |
|
|||||
|
2020
Q1 | $74K | Sell |
|
|||||
|
2019
Q4 | $133K | Hold |
|
|||||
|
2019
Q3 | $156K | Sell |
|
|||||
|
2019
Q2 | $240K | Buy |
|
|||||
|
2019
Q1 | $180K | Buy |
|
|||||
|
2018
Q4 | $73K | Sell |
|
|||||
|
2018
Q3 | $265K | Buy |
|
|||||
|
2018
Q2 | $484K | Sell |
|
|||||
|
2018
Q1 | $745K | Buy |
|
|||||
|
2017
Q4 | $831K | Buy |
|
|||||
|
2017
Q3 | $767K | Buy |
|
|||||
|
2017
Q2 | $111K | Buy |
|